Banco Santander’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Banco Santander’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,025	Closed	-$183K	–	428
2024 Q1	$183K	Sell	4,025 -2,263	-36%	-$103K	﹤0.01%	407
2023 Q4	$291K	Buy	6,288 +545	+9%	+$22.2K	﹤0.01%	382
2023 Q3	$234K	Sell	5,743 -45	-0.8%	-$2.05K	﹤0.01%	407
2023 Q2	$281K	Hold	5,788	–	–	﹤0.01%	387
2023 Q1	$285K	Sell	5,788 -762	-12%	-$39.2K	﹤0.01%	338
2022 Q4	$331K	Sell	6,550 -400	-6%	-$20.6K	﹤0.01%	331
2022 Q3	$349K	Sell	6,950 -3,958	-36%	-$223K	﹤0.01%	328
2022 Q2	$533K	Sell	10,908 -3,537	-24%	-$179K	0.01%	323
2022 Q1	$868K	Sell	14,445 -6,793	-32%	-$428K	0.01%	319
2021 Q4	$1.69M	Buy	21,238 +8,970	+73%	+$754K	0.01%	257
2021 Q3	$1.09M	Buy	+12,268	New	+$1.15M	0.01%	286

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Banco Santander's GNOM Position: Q2 2024 in Review

Banco Santander sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2024, closing a stake of 4,025 shares — an estimated $183K sold.

Banco Santander first reported a position in GNOM in Q3 2021 and held it in 11 quarters. The position peaked at $1.69M in Q4 2021. 64 funds tracked by Wall St. Rank hold GNOM as of Q2 2024.

Banco Santander reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Banco Santander sold 4,025 Global X Genomics & Biotechnology ETF shares in Q2 2024, an estimated $183K.
Banco Santander first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and held it in 11 quarters.
Banco Santander's Global X Genomics & Biotechnology ETF position peaked at $1.69M in Q4 2021.
64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2024.

Based on Banco Santander's 13F filing for Q2 2024, filed 29 Jul 2024.